ROYAL BANK OF CANADA - HEMISPHERX BIOPHARMA INC ownership

HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C301. A total of 22 filers reported holding HEMISPHERX BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of HEMISPHERX BIOPHARMA INC
ValueSharesWeighting
Q2 2018$1,0002,000
+9423.8%
0.00%
Q1 2018$021
-91.1%
0.00%
Q4 2017$02370.0%0.00%
Q3 2017$0237
+9.7%
0.00%
Q2 2017$02160.0%0.00%
Q1 2017$02160.0%0.00%
Q4 2016$02160.0%0.00%
Q3 2016$02160.00%
Other shareholders
HEMISPHERX BIOPHARMA INC shareholders Q3 2018
NameSharesValueWeighting ↓
Virtu Financial LLC 67,719$11,0000.00%
Occidental Asset Management, LLC 15,834$3,0000.00%
VANGUARD GROUP INC 361,415$58,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 2,080$00.00%
Sound Income Strategies, LLC 9$00.00%
HUNTINGTON NATIONAL BANK 2,501$00.00%
CITY HOLDING CO 417$00.00%
NORTHERN TRUST CORP 31,933$5,0000.00%
Waldron Private Wealth LLC 11,000$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of HEMISPHERX BIOPHARMA INC shareholders